| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |